# Ewout J. Hoorn

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ewout-j-hoorn/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,357 |
| Field | Electrolyte and hormonal disorders |
| h-index | 69 |
| i10-index | 246 |
| Last Known Institution | Erasmus MC |
| OpenAlex ID | https://openalex.org/A5027968873 |
| ORCID iD | https://orcid.org/0000-0002-8738-3571 |
| Works | 510 |

## Researcher papers

- [Clinical practice guideline on diagnosis and treatment of hyponatraemia](https://scholariq.org/papers/clinical-practice-guideline-on-diagnosis-and-treatment-of-hyponatraemia/)
- [Clinical practice guideline on diagnosis and treatment of hyponatraemia](https://scholariq.org/papers/clinical-practice-guideline-on-diagnosis-and-treatment-of-hyponatraemia-3/)
- [Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference](https://scholariq.org/papers/nomenclature-for-kidney-function-and-disease-report-of-a-kidney-disease/)
- [Clinical practice guideline on diagnosis and treatment of hyponatraemia](https://scholariq.org/papers/clinical-practice-guideline-on-diagnosis-and-treatment-of-hyponatraemia-2/)
- [Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/potassium-homeostasis-and-management-of-dyskalemia-in-kidney-diseases/)
- [GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes](https://scholariq.org/papers/glp-1-and-the-kidney-from-physiology-to-pharmacology-and-outcomes-in-diabetes/)
- [The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension](https://scholariq.org/papers/the-calcineurin-inhibitor-tacrolimus-activates-the-renal-sodium-chloride/)
- [The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial](https://scholariq.org/papers/the-renal-hemodynamic-effects-of-the-sglt2-inhibitor-dapagliflozin-are-caused-by/)
- [Urinary extracellular vesicles and the kidney: biomarkers and beyond](https://scholariq.org/papers/urinary-extracellular-vesicles-and-the-kidney-biomarkers-and-beyond/)

## Researcher topics

- [Electrolyte and hormonal disorders](https://scholariq.org/topics/electrolyte-and-hormonal-disorders/)
- [Ion Transport and Channel Regulation](https://scholariq.org/topics/ion-transport-and-channel-regulation/)
- [Potassium and Related Disorders](https://scholariq.org/topics/potassium-and-related-disorders/)
- [Renal function and acid-base balance](https://scholariq.org/topics/renal-function-and-acid-base-balance/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

## Researcher university

- [Erasmus MC](https://scholariq.org/institutions/erasmus-mc/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.